Charles River Laboratories | CRL - Trade Creditors


Charles River Laboratories reported $140.98M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
Agilent USD 608M 7M Jun/2026
Align Technology USD 109.84M 13.88M Jun/2026
Bio-Rad Laboratories USD 143.5M 10.4M Jun/2026
Bruker USD 200.2M 68.9M Jun/2026
Cardinal Health USD 38.28B 449M Jun/2026
Charles River Laboratories USD 140.98M 7.03M Jun/2026
Cigna USD 10.41B 530M Jun/2026
Concord Medical Services Hldg CNY 119.29M 7.1M Dec/2025
CVS Health USD 59.68B 1.09B Jun/2026
Danaher USD 2.07B 282M Jun/2026
Dentsply International USD 260M 1000K Jun/2026
Elevance Health USD 6.63B 423M Jun/2026
Humana USD 7.26B 732M Jun/2026
Illumina USD 230M 12M Jun/2026
Incyte USD 1.39B 1.16B Jun/2026
Intrexon USD 4.85M 3.12M Jun/2024
IQVIA Holdings USD 3.61B 31M Jun/2026
Laboratory Of America USD 688.5M 7.2M Jun/2026
Lakefront Biotherapeutics EUR 66.35M 29.42M Jun/2026
Lonza CHF 471M 3M Dec/2024
McKesson USD 63.73B 3.76B Jun/2026
Merck EUR 2.07B 61M Jun/2026
Mettler Toledo International USD 229.8M 1.08M Jun/2026
Novartis USD 4.26B 64M Jun/2026
Pfizer USD 4.58B 75M Jun/2026
Quest Diagnostics USD 1.6B 98M Jun/2026
Revvity USD 165.74M 3.94M Jun/2026
Thermo Fisher Scientific USD 3.34B 278M Mar/2026
United Therapeutics USD 497.8M 500K Jun/2026
UnitedHealth USD 78.29B 921M Mar/2026
Veradigm USD 30.84M 18.23M Dec/2022
Waters USD 602M 498.22M Mar/2026
West Pharmaceutical Services USD 252.7M 400K Jun/2026